NCT07108686View on ClinicalTrials.gov

Bleeding and Thrombotic Risk Prediction in Acute Leukemia: Clinical Utility of the Siriraj Acute Myeloid/Lymphoblastic Leukemia (SiAML) Score Versus Established Hemostatic Tools

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

December 1, 2026

Conditions
Acute Leukemia
All Listed Sponsors
lead

Assiut University

OTHER

NCT07108686 - Bleeding and Thrombotic Risk Prediction in Acute Leukemia: Clinical Utility of the Siriraj Acute Myeloid/Lymphoblastic Leukemia (SiAML) Score Versus Established Hemostatic Tools | Biotech Hunter | Biotech Hunter